Fresenius Medical Care AG & Co. KGaA (FMS)

FMS Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	19,474	19,454	19,398	17,619	17,859	17,477
Revenue Growth (YoY)	-0.41%	0.29%	10.10%	-1.35%	2.19%	5.62%
Cost of Revenue	14,524	14,529	14,504	12,846	12,322	12,081
Gross Profit	4,950	4,925	4,894	4,773	5,537	5,396
Selling, General & Admin	3,190	3,196	3,170	2,773	3,134	3,032
Research & Development	224.01	231.97	228.62	220.78	193.77	168.03
Other Operating Expenses	304.28	249.05	49.5	19.3	0	0
Operating Expenses	3,718	3,677	3,448	3,013	3,328	3,200
Operating Income	1,231	1,248	1,445	1,760	2,210	2,196
Interest Expense / Income	433.84	424.64	360.14	353.6	409.98	491.06
Other Expense / Income	18.41	23.46	86.7	84.38	134.98	103.59
Pretax Income	779.15	799.55	998.36	1,322	1,665	1,601
Income Tax	295.56	300.56	324.95	352.83	500.56	401.61
Net Income	483.59	499	673.41	969.31	1,164	1,200
Net Income Growth	-19.72%	-25.90%	-30.53%	-16.75%	-2.94%	-39.47%
Shares Outstanding (Basic)	293	293	293	293	298	307
Shares Change	-	-	0.18%	-1.83%	-2.79%	0.14%
EPS (Basic)	0.82	0.85	1.15	1.66	1.98	1.98
EPS (Diluted)	0.82	0.85	1.15	1.66	1.98	1.98
EPS Growth	-19.51%	-26.09%	-30.51%	-16.41%	0%	-38.60%
Free Cash Flow	1,956	1,960	1,480	1,660	3,197	1,454
Free Cash Flow Per Share	3.33	3.34	2.52	2.83	5.36	2.37
Dividend Per Share	0.618	0.618	0.709	0.834	0.707	0.655
Dividend Growth	-12.83%	-12.83%	-14.99%	17.96%	7.94%	3.64%
Gross Margin	25.42%	25.32%	25.23%	27.09%	31.01%	30.87%
Operating Margin	6.32%	6.41%	7.45%	9.99%	12.37%	12.56%
Profit Margin	2.48%	2.57%	3.47%	5.50%	6.52%	6.86%
Free Cash Flow Margin	10.04%	10.08%	7.63%	9.42%	17.90%	8.32%
Effective Tax Rate	37.93%	37.59%	32.55%	26.69%	30.06%	25.08%
EBITDA	3,040	2,976	3,197	3,299	3,861	3,685
EBITDA Margin	15.61%	15.30%	16.48%	18.73%	21.62%	21.09%
Depreciation & Amortization	1,827	1,752	1,838	1,624	1,786	1,593
EBIT	1,213	1,224	1,358	1,676	2,075	2,092
EBIT Margin	6.23%	6.29%	7.00%	9.51%	11.62%	11.97%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).